Skip to content

D&A at other companies

IQVIA logo
IQVIAIQV
$288M+8.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$661K+13.6%
Alkermes logo
AlkermesALKS
$11.68M
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$55.9M+15.5%
Arrowhead Research logo
Arrowhead ResearchARWR
Amgen logo
AmgenAMGN

Segments

By segment

See full
Reportable Segment Aggregation Before Other Operating$408K+97.1%

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$6.81B+189%
Enterprise value$6.37B+181%

Returns & leverage

See full
Current ratio32.6×+16.8×

Questions, answered.

What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.